Mark J. Robitaille

Mark J. Robitaille

Auto-generated profile, based on publicly available information

Mark J. Robitaille

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2022 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
RBRuma Bose
Ruma Bose
MMMario Montealegre-Gallegos
Mario Montealegre-Gallegos
JMJohn D. Mitchell
John D. Mitchell
ASAidan Sharkey
Aidan Sharkey
SSSankalp Sehgal
Sankalp Sehgal
FMFeroze Mahmood
Feroze Mahmood

15 June 2026 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
BPBéla-Simon Paschold
Béla-Simon Paschold
BBBen L.P. Braeuer
Ben L.P. Braeuer
PSPeter Santer
Peter Santer
LWLisa-Marie Wichelhaus
Lisa-Marie Wichelhaus
GAGlasiele Alcala
Glasiele Alcala
MSMaximilian Sebastian Schaefer
Maximilian Sebastian Schaefer

12 November 2026 in Anesthesiology
Verified
Journal Article
Closed access
MRMark J. Robitaille
Mark J. Robitaille
Sebastian D SahliSebastian D Sahli
Sebastian D Sahli
LWLuca J. Wachtendorf
Luca J. Wachtendorf
BBBen L. P. Braeuer
Ben L. P. Braeuer
KLKara Liebich
Kara Liebich
CMCarsten Patrick Marcus
Carsten Patrick Marcus
Background: Oxygen delivery during cardiopulmonary bypass reflects the balance between pump flow, hemoglobin concentration, and arterial oxygenation and is a key determinant of tissue oxygen transport. While inadequate oxygen delivery has been linked to postoperative organ dysfunction, its association with mortality remains unclear. Methods: A retrospective cohort study was conducted including 4,358 adult patients undergoing cardiac surgery with cardiopulmonary bypass at a tertiary center between 2018 and 2024. Time-weighted average indexed oxygen delivery (DO 2i ) was calculated from pump flow, arterial oxygen saturation, hemoglobin concentration, and body surface area. The primary outcome was 30-day mortality. Secondary outcomes included postoperative acute kidney injury (AKI), stroke, and intensive care unit and hospital length of stay. Associations were evaluated using multivariable regression models adjusted for demographic, clinical, and procedural factors. Results: Lower intraoperative DO 2i was associated with higher 30-day mortality. Overall, 75 patients (1.7%) died within 30 days. Each 10-ml · min −1 · m −2 decrease in DO 2i was associated with increased odds of mortality (adjusted odds ratio [OR adj ], 1.16; 95% CI, 1.09 to 1.23; P < 0.001). The adjusted 30-day mortality was 1.69% (95% CI, 1.32 to 2.05%) at the 25th percentile of DO 2i (226.2 ml · min −1 · m −2 ) compared with 0.74% (95% CI 0.41 to 1.07%) at the 75th percentile (295.6 ml · min −1 · m −2 ). Lower DO 2i was also associated with AKI (OR adj , 1.05; 95% CI, 1.03 to 1.07; P < 0.001) and with longer intensive care unit (adjusted incidence rate ratio, 1.02; 95% CI, 1.01 to 1.03; P < 0.001) and hospital length of stay (adjusted incidence rate ratio, 1.01; 95% CI, 1.01–1.02; P < 0.001) but not with stroke (OR adj , 1.00; 95% CI, 0.95 to 1.06; P = 0.877). Conclusions: Patients receiving lower intraoperative DO 2i during cardiopulmonary bypass had a higher risk of postoperative mortality, AKI, and prolonged recovery. These findings support the clinical relevance of oxygen delivery during bypass and provide a rationale for future mechanistic and interventional studies.

15 April 2026 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
SRSophia Riesemann
Sophia Riesemann
LWLuca J. Wachtendorf
Luca J. Wachtendorf
BBBen L. P. Braeuer
Ben L. P. Braeuer
Sebastian D SahliSebastian D Sahli
Sebastian D Sahli
BPBéla-Simon Paschold
Béla-Simon Paschold
MRMark J. Robitaille
Mark J. Robitaille
The respiratory exchange ratio (RER), defined as the ratio of carbon dioxide (CO2) production to oxygen (O2) consumption, may be a non-invasive and continuously measurable alternative to lactate for identifying patients at risk of postoperative complications that has been examined in non-cardiac surgery. We investigated whether intraoperative RER predicts blood lactate levels and postoperative complications in cardiac surgery. This retrospective cohort study included adult patients undergoing cardiac surgery with cardiopulmonary bypass at Beth Israel Deaconess Medical Center in Boston, USA, between 2008 and 2020. Intraoperative minute-by-minute data of inspired and expired fractions of CO2 and O2 were analyzed. Univariable and a priori-defined multivariable logistic regression models were used to evaluate the association between the median RER during surgery, intraoperative lactate and 7-day major postoperative complications (European Perioperative Clinical Outcome Definitions). 324,646 RER calculations of 4,058 patients were included. 1,745 (43.0%) patients experienced 7-day postoperative complications. The median (IQR) RER was 0.64 (0.48–0.92) before and 0.65 (0.48–0.97) after bypass. The RER within 10 min prior to lactate testing was associated with lactate levels > 2 mmol/l (adjusted odds ratio [ORadj] 1.11, 95% confidence interval [CI] 1.01–1.23, p = 0.031). Neither RER before nor after bypass was associated with 7-day postoperative complications (before bypass: ORadj 1.02, 95%CI 0.95–1.10, p = 0.55; after bypass: ORadj 1.03, 95%CI 0.95–1.13, p = 0.46). While RER showed a modest relationship with hyperlactatemia, its utility as a predictor of postoperative complications appears limited in real-world data. Further research is needed to clarify its role and potential for clinical applicability.